GHK-Cu
Collagen synthesis; antioxidant gene upregulation (SOD, catalase); DNA repair via FOXO3a
Melanotan I
AdjacentResearch ongoing — see primary literature for current evidence.
Clinical Decision Framework
When evaluating GHK-Cu versus Melanotan I for biological age reduction, the primary consideration is the specific hallmark of aging being targeted. While both compounds offer systemic healthspan benefits, their mechanisms of action are distinct.
When to prioritize GHK-Cu:
Select GHK-Cu when the primary clinical objective aligns with its core mechanism: copper-binding tripeptide that activates over 4,000 genes involved in collagen synthesis, antioxidant defense, and tissue remodeling.. This is particularly relevant for protocols focused on skin regeneration, collagen synthesis, and systemic anti-aging gene activation..
When to prioritize Melanotan I:
Conversely, Melanotan I is the superior choice when targeting selective mc1r agonist that stimulates melanin production with a more favorable side effect profile than melanotan ii., making it the preferred agent for uv-independent skin tanning and photoprotection..
Begin Your Age Reversal Protocol for GHK-Cu or Melanotan I
Alukard provides physician-supervised longevity protocols with GMP-certified compounds, biomarker testing, and personalized biological age reduction programs.
HIPAA Compliant · GMP Certified · Physician Supervised · Biomarker Testing